gout

Novo Nordisk
Biotech

Novo drops oncology ambitions, early-stage MASH prospects

The Danish pharma is winding down a range of early-stage programs for liver disease, oncology and stem cells.
James Waldron Nov 5, 2025 7:21am
money flying in

Arthrosi raises $153M, fueling dash toward phase 3 gout data

Oct 8, 2025 10:15am
A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
Digital molecular structure

Atom claims ph. 3 win shows gout drug can beat competition

Sep 8, 2025 9:01am
Neglected dying tropical Syngonum Neon Robusta house plant in white flower pot on pink background

George Church spinout restructures, considers strategic options

Mar 13, 2025 2:00pm
Gout foot

GRO Bio gathers $60M series B to take gout therapy into clinic

Jul 19, 2024 9:59am